Webull has launched Webull Connect, a portfolio management and execution platform designed specifically for Australian financial advisers, marking the firm’s ...
Webull Connect is designed to provide Australian financial advisers access to multi-currency Australian, U.S. and Hong Kong ...
Webull Corporation (NASDAQ: BULL) today announced that it will release its fourth quarter 2025 earnings results after market ...
Editor’s Note: This article has been updated to reflect Webull’s correct subscription price of $4.99. A previous version, based on information provided by the company, included an incorrect price.
Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it is ...
Live video webcast on Wednesday, February 11 th at 1:40 PM EST OCALA, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today that it will ...
OCALA, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM” or the "Company”), today that it will participate in the Corporate Connect Webinar Series hosted by ...
TAMPA, Fla. and LONDON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company pioneering next-generation antibody drug conjugates (ADCs) powered ...
Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it will ...
Webull Corp stock reached a 52-week low of 6.4 USD, reflecting a challenging year for the company. According to InvestingPro data, the stock is currently trading just 1% above its 52-week low of $6.41 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results